|
KURT H. KRUGER - Chief Financial Officer. Prior to joining Cyberkinetics in September 2006, Mr. Kruger was with Banc of America Securities LLC, (formerly Montgomery Securities) and Hambrecht & Quist, where he served as Managing Director and Medical Technology Research Analyst. In that role, he followed a wide range of medical technology companies, including Johnson & Johnson, Medtronic, Inc., Boston Scientific Corporation and Zimmer, Inc. In addition, Mr. Kruger structured financings that raised more than $3.2 billion for more than two dozen companies, including Ventritex, Inc., Target Therapeutics, Heart Technology, Cytyc Corporation, Cyberonics, Inc., and Kyphon Inc. Kruger also worked with Cardiac Pacemakers, Inc., a subsidiary of Eli Lilly and Company that became Guidant Corporation. Mr. Kruger earned his Master of Science degree in Management from the MIT Sloan School of Management in Cambridge, Massachusetts. He also earned his Master of Science degree in Biomedical Engineering from the University of Michigan in Ann Arbor, and his Bachelor of Science Degree in Biomedical Engineering from Brown University in Providence, Rhode Island. In addition, he also completed course work at Columbia University in the pre-med program and was a Research Associate in the Cardiothoracic Surgery Lab at the New York Presbyterian Hospital. | 